Expert Interview
Discussing Bristol-Myers Squibb's PAISLEY Phase II PRO Data on Deucravacitinib as a Treatment for Systemic Lupus Erythematosus (SLE)
Ticker(s): BMY, AZN, GSK, ABBVInstitution: University of Washington
- Clinical Associate Professor in Rheumatology at the University of Washington.
- Treats 50 patients with psoriatic arthritis
- Research focuses on studying biomarkers to assess autoimmune, rheumatic diseases and developing new treatment options for inflammatory conditions refractory to current standard therapy.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
